{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:06:45Z","timestamp":1790996805120,"version":"4.1.0"},"reference-count":215,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Sufficient ocular bioavailability is often considered a challenge by the researchers, due to the complex structure of the eye and its protective physiological mechanisms. In addition, the low viscosity of the eye drops and the resulting short ocular residence time further contribute to the observed low drug concentration at the target site. Therefore, various drug delivery platforms are being developed to enhance ocular bioavailability, provide controlled and sustained drug release, reduce the number of applications, and maximize therapy outcomes. Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) exhibit all these benefits, in addition to being biocompatible, biodegradable, and susceptible to sterilization and scale-up. Furthermore, their successive surface modification contributes to prolonged ocular residence time (by adding cationic compounds), enhanced penetration, and improved performance. The review highlights the salient characteristics of SLNs and NLCs concerning ocular drug delivery, and updates the research progress in this area.<\/jats:p>","DOI":"10.3390\/ph16030474","type":"journal-article","created":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T03:07:57Z","timestamp":1679540877000},"page":"474","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["Recent Progress of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as Ocular Drug Delivery Platforms"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6681-8150","authenticated-orcid":false,"given":"Viliana","family":"Gugleva","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Technologies, Faculty of Pharmacy, Medical University of Varna, 55 Marin Drinov Str., 9000 Varna, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7369-1506","authenticated-orcid":false,"given":"Velichka","family":"Andonova","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Technologies, Faculty of Pharmacy, Medical University of Varna, 55 Marin Drinov Str., 9000 Varna, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,22]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2019). World Report on Vision, World Health Organization."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.4103\/ijo.IJO_3500_20","article-title":"Impact of the use of digital devices on eyes during the lockdown period of COVID-19 pandemic","volume":"69","author":"Usgaonkar","year":"2021","journal-title":"Ind. J. Ophthalmol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.36953\/ECJ.2019.SE02013","article-title":"Life style disorders in ophthalmology and their management","volume":"20","author":"Shalini","year":"2019","journal-title":"Environ. Conserv. J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"101539","DOI":"10.1016\/j.clae.2021.101539","article-title":"Systemic, environmental and lifestyle risk factors for dry eye disease in a mediterranean caucasian population","volume":"45","author":"Wolffsohn","year":"2022","journal-title":"Cont. Lens Anterior Eye."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1016\/S2214-109X(20)30425-3","article-title":"Trends in prevalence of blindness and distance and near vision impairment over 30 years: An analysis for the Global Burden of Disease Study","volume":"9","author":"Bourne","year":"2021","journal-title":"Lancet Glob. Health."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1124\/jpet.119.256933","article-title":"Ocular Drug Delivery: Present Innovations and Future Challenges","volume":"370","author":"Gote","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5497\/wjp.v2.i2.47","article-title":"Ocular drug delivery systems: An overview","volume":"2","author":"Patel","year":"2013","journal-title":"World J. Pharmacol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.biopha.2018.08.138","article-title":"A review on recent drug delivery systems for posterior segment of eye","volume":"107","author":"Nayak","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Bachu, R.D., Chowdhury, P., Al-Saedi, Z.H.F., Karla, P.K., and Boddu, S.H.S. (2018). Ocular Drug Delivery Barriers-Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases. Pharmaceutics, 10.","DOI":"10.3390\/pharmaceutics10010028"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Tovey, G.D. (2022). Specialized Pharmaceutical Formulation: The Science and Technology of Dosage Forms, Royal Society of Chemistry. [1st ed.].","DOI":"10.1039\/9781839165603"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3390\/polym3010193","article-title":"Recent Advances in Ocular Drug Delivery Systems","volume":"3","author":"Kuno","year":"2011","journal-title":"Polymers"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5603\/OJ.2016.0005","article-title":"Drug bioavailability from topically applied ocular drops. Does drop size matter?","volume":"1","author":"Ozimek","year":"2016","journal-title":"Ophthalmol. J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e17105","DOI":"10.1590\/s2175-97902019000117105","article-title":"Preparation and characterization of novel, mucoadhesive ofloxacin nanoparticles for ocular drug delivery","volume":"55","author":"Taghe","year":"2019","journal-title":"Braz. J. Pharm. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","article-title":"Ocular drug delivery","volume":"12","author":"Gaudana","year":"2010","journal-title":"AAPS J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"861904","DOI":"10.1155\/2014\/861904","article-title":"Ophthalmic drug dosage forms: Characterisation and research methods","volume":"2014","author":"Baranowski","year":"2014","journal-title":"Sci. World J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajps.2018.04.008","article-title":"Research progress of in-situ gelling ophthalmic drug delivery system","volume":"14","author":"Wu","year":"2019","journal-title":"Asian J. Pharm. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/tmi.12276","article-title":"Posterior segment eye disease in sub-Saharan Africa: Review of recent population-based studies","volume":"19","author":"Bastawrous","year":"2014","journal-title":"Trop. Med. Int. Health."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1556\/650.2022.32440","article-title":"H\u00e1ts\u00f3szegmens-betegs\u00e9gek okozta l\u00e1t\u00e1sroml\u00e1s \u00e9s vaks\u00e1g Magyarorsz\u00e1gon az 50 \u00e9vn\u00e9l idosebb kor\u00fa lakoss\u00e1g k\u00f6r\u00e9ben [Visual impairment and blindness caused by posterior segment diseases in Hungary in people aged 50 years and older]","volume":"163","author":"Nagy","year":"2022","journal-title":"Orv. Hetil."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Varela-Fern\u00e1ndez, R., D\u00edaz-Tom\u00e9, V., Luaces-Rodr\u00edguez, A., Conde-Penedo, A., Garc\u00eda-Otero, X., Luzardo-\u00c1lvarez, A., Fern\u00e1ndez-Ferreiro, A., and Otero-Espinar, F.J. (2020). Drug Delivery to the Posterior Segment of the Eye: Biopharmaceutic and Pharmacokinetic Considerations. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12030269"},{"key":"ref_20","unstructured":"Grumezescu, A. (2018). Drug Targeting and Stimuli Sensitive Drug Delivery Systems, Elsevier. [1st ed.]."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejpb.2016.10.009","article-title":"Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye\u2014Part I\u2014Barriers and determining factors in ocular delivery","volume":"110","author":"Espina","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"19285","DOI":"10.1038\/s41598-020-76381-y","article-title":"Besifloxacin liposomes with positively charged additives for an improved topical ocular delivery","volume":"10","author":"Dalmolin","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"838168","DOI":"10.3389\/fphar.2022.838168","article-title":"Tacrolimus Loaded Cationic Liposomes for Dry Eye Treatment","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1080\/03639045.2020.1755305","article-title":"Latanoprost niosomes as a sustained release ocular delivery system for the management of glaucoma","volume":"46","author":"Fathalla","year":"2020","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1080\/03639045.2019.1579827","article-title":"Natamycin niosomes as a promising ocular nanosized delivery system with ketorolac tromethamine for dual effects for treatment of candida rabbit keratitis; in vitro\/in vivo and histopathological studies","volume":"45","author":"Teaima","year":"2019","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Vicente-Pascual, M., G\u00f3mez-Aguado, I., Rodr\u00edguez-Castej\u00f3n, J., Rodr\u00edguez-Gasc\u00f3n, A., Muntoni, E., Battaglia, L., del Pozo-Rodr\u00edguez, A., and Solin\u00eds Aspiazu, M.\u00c1. (2020). Topical Administration of SLN-Based Gene Therapy for the Treatment of Corneal Inflammation by De Novo IL-10 Production. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12060584"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1500347","DOI":"10.1080\/19932820.2018.1500347","article-title":"An approach to revolutionize cataract treatment by enhancing drug probing through intraocular cell line","volume":"13","author":"Wang","year":"2018","journal-title":"Libyan J. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1186\/s12951-021-01199-3","article-title":"Polydopamine nanoparticles attenuate retina ganglion cell degeneration and restore visual function after optic nerve injury","volume":"19","author":"Lou","year":"2021","journal-title":"J. Nanobiotechnology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1038\/s41467-022-31368-3","article-title":"Light-induced charge generation in polymeric nanoparticles restores vision in advanced-stage retinitis pigmentosa rats","volume":"13","author":"Francia","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Rinc\u00f3n, M., Espinoza, L.C., Silva-Abreu, M., Sosa, L., Pesantez-Narvaez, J., Abrego, G., Calpena, A.C., and Mallandrich, M. (2022). Quality by Design of Pranoprofen Loaded Nanostructured Lipid Carriers and Their Ex Vivo Evaluation in Different Mucosae and Ocular Tissues. Pharmaceuticals, 15.","DOI":"10.3390\/ph15101185"},{"key":"ref_31","first-page":"412","article-title":"Design of Besifloxacin HCl-Loaded Nanostructured Lipid Carriers: In Vitro and Ex Vivo Evaluation","volume":"38","author":"Polat","year":"2022","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.actbio.2022.01.014","article-title":"Rational design of mixed nanomicelle eye drops with structural integrity investigation","volume":"141","author":"Sun","year":"2022","journal-title":"Acta Biomater."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"115356","DOI":"10.1016\/j.carbpol.2019.115356","article-title":"Functional chitosan oligosaccharide nanomicelles for topical ocular drug delivery of dexamethasone","volume":"227","author":"Xu","year":"2020","journal-title":"Carbohydr. Polym."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1080\/09205063.2020.1740964","article-title":"PEGylated microemulsion for dexamethasone delivery to posterior segment of eye","volume":"31","author":"Nayak","year":"2020","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1089\/jop.2017.0082","article-title":"Development and Evaluation of a Novel Microemulsion of Dexamethasone and Tobramycin for Topical Ocular Administration","volume":"34","author":"Bachu","year":"2018","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1021\/acs.molpharmaceut.6b00182","article-title":"Novel Water-Soluble Mucoadhesive Carbosilane Dendrimers for Ocular Administration","volume":"13","author":"Ponchel","year":"2016","journal-title":"Mol. Pharm."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4103\/1735-5362.235156","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: Applications, advantages and disadvantages","volume":"13","author":"Ghasemiyeh","year":"2018","journal-title":"Res. Pharm. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Costa, C.P., Barreiro, S., Moreira, J.N., Silva, R., Almeida, H., Sousa Lobo, J.M., and Silva, A.C. (2021). In Vitro Studies on Nasal Formulations of Nanostructured Lipid Carriers (NLC) and Solid Lipid Nanoparticles (SLN). Pharmaceuticals, 14.","DOI":"10.3390\/ph14080711"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"100064","DOI":"10.1016\/j.onano.2022.100064","article-title":"Nanostructured lipid carriers and their potential applications for versatile drug delivery via oral administration","volume":"8","author":"Nguyen","year":"2022","journal-title":"OpenNano"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.pharep.2018.10.008","article-title":"Nanostructured lipid carriers: A potential use for skin drug delivery systems","volume":"71","author":"Szekalska","year":"2019","journal-title":"Pharmacol. Rep."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Musielak, E., Feliczak-Guzik, A., and Nowak, I. (2022). Optimization of the Conditions of Solid Lipid Nanoparticles (SLN) Synthesis. Molecules, 27.","DOI":"10.3390\/molecules27072202"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"FSO135","DOI":"10.4155\/fsoa-2016-0030","article-title":"Nanostructured lipid carriers: Versatile oral delivery vehicle","volume":"2","author":"Poonia","year":"2016","journal-title":"Future Sci. OA"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Abo El-Enin, H.A., Elkomy, M.H., Naguib, I.A., Ahmed, M.F., Alsaidan, O.A., Alsalahat, I., Ghoneim, M.M., and Eid, H.M. (2022). Lipid Nanocarriers Overlaid with Chitosan for Brain Delivery of Berberine via the Nasal Route. Pharmaceuticals, 15.","DOI":"10.3390\/ph15030281"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jconrel.2021.05.032","article-title":"Solid lipid nanoparticles for hydrophilic drugs","volume":"335","author":"Mirchandani","year":"2021","journal-title":"J. Control Release."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"495103","DOI":"10.1088\/0957-4484\/26\/49\/495103","article-title":"Solid lipid nanoparticles as a vehicle for brain-targeted drug delivery: Two new strategies of functionalization with apolipoprotein E","volume":"26","author":"Neves","year":"2015","journal-title":"Nanotechnology"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Lee, W.J. (2019). Vitamin C in Human Health and Disease, Springer. [1st ed.].","DOI":"10.1007\/978-94-024-1713-5"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0014-4835(03)00212-4","article-title":"Scleral structure, organisation and disease. A review","volume":"78","author":"Watson","year":"2004","journal-title":"Exp. Eye Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4103\/ijo.IJO_646_17","article-title":"Anatomy of cornea and ocular surface","volume":"66","author":"Sridhar","year":"2018","journal-title":"Indian J. Ophthalmol."},{"key":"ref_49","unstructured":"Zachary, J.F. (2017). Pathologic Basis of Veterinary Disease, Elsevier. [6th ed.]."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Moiseev, R.V., Morrison, P.W.J., Steele, F., and Khutoryanskiy, V.V. (2019). Penetration Enhancers in Ocular Drug Delivery. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11070321"},{"key":"ref_51","unstructured":"Ferreri, F.M. (2018). Anatomy of the Human Optic Nerve: Structure and Function, IntechOpen."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"39603","DOI":"10.1021\/acsami.9b13851","article-title":"Overcoming the Anatomical and Physiological Barriers in Topical Eye Surface Medication Using a Peptide-Decorated Polymeric Micelle","volume":"11","author":"Lin","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_53","unstructured":"Gu, N. (2022). Nanomedicine, Springer. [1st ed.]."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.exer.2013.07.014","article-title":"Antimicrobial Compounds in Tears","volume":"117","author":"McDermott","year":"2013","journal-title":"Exp. Eye Res."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Kopacz, D. (2021). Ocular Surface Diseases\u2014Some Current Date on Tear Film Problem and Keratoconic Diagnosis, IntechOpen. [1st ed.].","DOI":"10.5772\/intechopen.77516"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jtos.2017.03.006","article-title":"TFOS DEWS II Tear Film Report","volume":"15","author":"Willcox","year":"2017","journal-title":"Ocul. Surf."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"109006","DOI":"10.1016\/j.exer.2022.109006","article-title":"Topical ocular drug delivery systems: Innovations for an unmet need","volume":"218","author":"Yang","year":"2022","journal-title":"Exp. Eye Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2020.01.057","article-title":"Advances and limitations of drug delivery systems formulated as eye drops","volume":"321","author":"Jumelle","year":"2020","journal-title":"J. Control Release."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1089\/biores.2016.0008","article-title":"In Vitro Cell Models for Ophthalmic Drug Development Applications","volume":"5","author":"Shafaie","year":"2016","journal-title":"Biores. Open Access."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Peris-Mart\u00ednez, C., Garc\u00eda-Domene, M.C., Penad\u00e9s, M., Luque, M.J., Fern\u00e1ndez-L\u00f3pez, E., and Artigas, J.M. (2021). Spectral Transmission of the Human Corneal Layers. J. Clin. Med., 10.","DOI":"10.3390\/jcm10194490"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Ruan, Y., Jiang, S., Musayeva, A., Pfeiffer, N., and Gericke, A. (2021). Corneal Epithelial Stem Cells-Physiology, Pathophysiology and Therapeutic Options. Cells, 10.","DOI":"10.3390\/cells10092302"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Shastri, D.H., Silva, A.C., and Almeida, H. (2023). Ocular Delivery of Therapeutic Proteins: A Review. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15010205"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1080\/1061186X.2021.1878366","article-title":"A review of nanocarrier-mediated drug delivery systems for posterior segment eye disease: Challenges analysis and recent advances","volume":"29","author":"Wang","year":"2021","journal-title":"J. Drug Target"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3109\/03602532.2014.921190","article-title":"Ocular cytochrome P450s and transporters: Roles in disease and endobiotic and xenobiotic disposition","volume":"46","author":"Nakano","year":"2014","journal-title":"Drug Metab. Rev."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1080\/02713683.2019.1663874","article-title":"Corneal Stromal Regeneration: Current Status and Future Therapeutic Potential","volume":"45","author":"Lagali","year":"2020","journal-title":"Curr. Eye Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.4155\/tde.14.75","article-title":"Advances in ophthalmic drug delivery","volume":"5","author":"Morrison","year":"2014","journal-title":"Ther. Deliv."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s13346-016-0339-2","article-title":"A comprehensive insight on ocular pharmacokinetics","volume":"6","author":"Agrahari","year":"2016","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.compbiomed.2017.11.009","article-title":"Computational Modeling of Drug Transport Across the In Vitro Cornea","volume":"92","author":"Pak","year":"2018","journal-title":"Comput. Biol. Med."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"L\u00f6scher, M., Seiz, C., Hurst, J., and Schnichels, S. (2022). Topical Drug Delivery to the Posterior Segment of the Eye. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14010134"},{"key":"ref_70","first-page":"9","article-title":"Nanotechnological approaches in Ophthalmic delivery systems","volume":"3","author":"Harikumar","year":"2011","journal-title":"Int. J. Drug Dev. Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"78","DOI":"10.5497\/wjp.v2.i4.78","article-title":"Drug delivery in ocular diseases: Barriers and strategies","volume":"2","author":"Kwatra","year":"2013","journal-title":"World J. Pharmacol."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Akhter, M.H., Ahmad, I., Alshahrani, M.Y., Al-Harbi, A.I., Khalilullah, H., Afzal, O., Altamimi, A.S.A., Najib Ullah, S.N.M., Ojha, A., and Karim, S. (2022). Drug Delivery Challenges and Current Progress in Nanocarrier-Based Ocular Therapeutic System. Gels, 8.","DOI":"10.3390\/gels8020082"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"119831","DOI":"10.1016\/j.ijpharm.2020.119831","article-title":"Cutting-edge advances in therapy for the posterior segment of the eye: Solid lipid nanoparticles and nanostructured lipid carriers","volume":"589","author":"Barbosa","year":"2020","journal-title":"Int. J. Pharm."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Pescina, S., Lucca, L.G., Govoni, P., Padula, C., Favero, E.D., Cant\u00f9, L., Santi, P., and Nicoli, S. (2019). Ex Vivo Conjunctival Retention and Transconjunctival Transport of Poorly Soluble Drugs Using Polymeric Micelles. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11090476"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ejpb.2004.12.007","article-title":"Roles of the conjunctiva in ocular drug delivery: A review of conjunctival transport mechanisms and their regulation","volume":"60","author":"Hosoya","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.3389\/fneur.2018.01069","article-title":"Functional Organization of the Sympathetic Pathways Controlling the Pupil: Light-Inhibited and Light-Stimulated Pathways","volume":"9","author":"Szabadi","year":"2018","journal-title":"Front. Neurol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.1021\/acs.molpharmaceut.9b00769","article-title":"Establishment of an In vitro-In vivo Correlation for Melanin Binding and the Extension of the Ocular Half-Life of Small-Molecule Drugs","volume":"16","author":"Jakubiak","year":"2019","journal-title":"Mol. Pharm."},{"key":"ref_78","first-page":"1541","article-title":"Basics of ocular drug delivery systems","volume":"2","author":"Tangri","year":"2011","journal-title":"Int. J. Res. Pharm. Biomed. Sci."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.addr.2017.12.008","article-title":"Implications of melanin binding in ocular drug delivery","volume":"126","author":"Reinisalo","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jconrel.2018.05.034","article-title":"Melanin targeting for intracellular drug delivery: Quantification of bound and free drug in retinal pigment epithelial cells","volume":"283","author":"Kidron","year":"2018","journal-title":"J. Control Release"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.3109\/03639045.2012.736515","article-title":"Recent advances in ocular drug delivery","volume":"39","author":"Achouri","year":"2013","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Dubald, M., Bourgeois, S., Andrieu, V., and Fessi, H. (2018). Ophthalmic Drug Delivery Systems for Antibiotherapy\u2014A Review. Pharmaceutics, 10.","DOI":"10.3390\/pharmaceutics10010010"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3109\/10717544.2010.483257","article-title":"Solid lipid nanoparticles for ocular drug delivery","volume":"7","author":"Seyfoddin","year":"2010","journal-title":"Drug Deliv."},{"key":"ref_84","first-page":"700","article-title":"Colloidal drug delivery system: Amplify the ocular delivery","volume":"23","author":"Ali","year":"2014","journal-title":"Drug Deliv."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/bs.pmbts.2015.04.006","article-title":"Overview of the Lens","volume":"134","author":"Hejtmancik","year":"2015","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e000459","DOI":"10.1136\/bmjophth-2020-000459","article-title":"The structure of the lens and its associations with the visual quality","volume":"5","author":"Ruan","year":"2020","journal-title":"BMJ Open Ophthalmol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"410061","DOI":"10.1115\/1.4029430","article-title":"Collagen structure and mechanical properties of the human sclera: Analysis for the effects of age","volume":"137","author":"Coudrillier","year":"2015","journal-title":"J. Biomech. Eng."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"114342","DOI":"10.1016\/j.addr.2022.114342","article-title":"Polymer based sustained drug delivery to the ocular posterior segment: Barriers and future opportunities for the treatment of neovascular pathologies","volume":"187","author":"Alshaikh","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Patel, J.K., Sutariya, V., Kanwar, J.R., and Pathak, Y.V. (2018). Drug Delivery for the Retina and Posterior Segment Disease, Springer. [1st ed.].","DOI":"10.1007\/978-3-319-95807-1"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.actbio.2018.11.033","article-title":"Characterization of a tissue-engineered choroid","volume":"84","author":"Djigo","year":"2019","journal-title":"Acta Biomater."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1146\/annurev-vision-100419-115156","article-title":"Retina Metabolism and Metabolism in the Pigmented Epithelium: A Busy Intersection","volume":"7","author":"Hurley","year":"2021","journal-title":"Annu. Rev. Vis. Sci."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.preteyeres.2016.12.001","article-title":"Pharmacokinetic aspects of retinal drug delivery","volume":"57","author":"Heikkinen","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Naylor, A., Hopkins, A., Hudson, N., and Campbell, M. (2019). Tight Junctions of the Outer Blood Retina Barrier. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21010211"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3389\/fphys.2014.00199","article-title":"Origins and consequences of hyperosmolar stress in retinal pigmented epithelial cells","volume":"5","author":"Willermain","year":"2014","journal-title":"Front. Physiol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.visres.2017.05.009","article-title":"The inner blood-retinal barrier: Cellular basis and development","volume":"139","author":"Ramos","year":"2017","journal-title":"Vision Res."},{"key":"ref_96","first-page":"9","article-title":"The Vitreous Body and Its Role in the Diagnosis of Eye Pathologies","volume":"9","author":"Santisteban","year":"2021","journal-title":"Med. Res. Arch."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/02713683.2022.2119254","article-title":"Vitreous Humor: Composition, Characteristics and Implication on Intravitreal Drug Delivery","volume":"48","author":"Mishra","year":"2022","journal-title":"Curr. Eye Res."},{"key":"ref_98","first-page":"15","article-title":"Administering a subconjunctival injection","volume":"22","author":"Stevens","year":"2009","journal-title":"Community Eye Health J."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1007\/s10792-020-01391-8","article-title":"Sustained subconjunctival drug delivery systems: Current trends and future perspectives","volume":"40","author":"Rafiei","year":"2020","journal-title":"Int. Ophthalmol."},{"key":"ref_100","first-page":"1932","article-title":"Intracameral lidocaine as supplement to classic topical anesthesia for relieving ocular pain in cataract surgery","volume":"11","author":"Nebbioso","year":"2018","journal-title":"Int. J. Ophthalmol."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Alghamdi, E.A.S., Al Qahtani, A.Y., Sinjab, M.M., and Alyahya, K.M. (2020). Extemporaneous Ophthalmic Preparations, Springer. [1st ed.].","DOI":"10.1007\/978-3-030-27492-4"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.2147\/OPTH.S165722","article-title":"Intracameral dexamethasone injection in the treatment of cataract surgery induced inflammation: Design, development, and place in therapy","volume":"12","author":"Shah","year":"2018","journal-title":"Clin. Ophthalmol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s13346-021-01043-z","article-title":"In vitro dissolution testing models of ocular implants for posterior segment drug delivery","volume":"12","author":"Adrianto","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/03000605221089807","article-title":"Suprachoroidal injection of triamcinolone acetonide using a custom-made needle to treat diabetic macular edema post pars plana vitrectomy: A case series","volume":"50","author":"Marashi","year":"2022","journal-title":"J. Int. Med. Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.addr.2018.03.001","article-title":"The suprachoroidal space as a route of administration to the posterior segment of the eye","volume":"126","author":"Chiang","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"xli","DOI":"10.1016\/j.ajo.2017.12.019","article-title":"Evolution of Intravitreal Therapy for Retinal Diseases-From CMV to CNV: The LXXIV Edward Jackson Memorial Lecture","volume":"191","author":"Martin","year":"2018","journal-title":"Am. J. Ophthalmol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"27835","DOI":"10.1039\/D0RA04971A","article-title":"Nanocarriers for ocular drug delivery: Current status and translational opportunity","volume":"10","author":"Gorantla","year":"2020","journal-title":"RSC Adv."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jconrel.2022.03.031","article-title":"Bibliometric and visualized analysis of ocular drug delivery from 2001 to 2020","volume":"345","author":"Peng","year":"2022","journal-title":"J. Control Release."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"103780","DOI":"10.1016\/j.jddst.2022.103780","article-title":"Lipid-based nanocarriers for ocular drug delivery: An updated review","volume":"76","author":"Das","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1208\/s12249-020-01807-9","article-title":"Atorvastatin Solid Lipid Nanoparticles as a Promising Approach for Dermal Delivery and an Anti-inflammatory Agent","volume":"21","author":"Shahraeini","year":"2020","journal-title":"AAPS PharmSciTech."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Essaghraoui, A., Belfkira, A., Hamdaoui, B., Nunes, C., Lima, S.A.C., and Reis, S. (2019). Improved Dermal Delivery of Cyclosporine A Loaded in Solid Lipid Nanoparticles. Nanomaterials, 9.","DOI":"10.3390\/nano9091204"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1080\/1061186X.2020.1871483","article-title":"Lipo-PEG nano-ocular formulation successfully encapsulates hydrophilic fluconazole and traverses corneal and non-corneal path to reach posterior eye segment","volume":"29","author":"Kakkar","year":"2021","journal-title":"J. Drug Target"},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"G\u00f3mez-Aguado, I., Rodr\u00edguez-Castej\u00f3n, J., Beraza-Millor, M., Vicente-Pascual, M., Rodr\u00edguez-Gasc\u00f3n, A., Garelli, S., Battaglia, L., del Pozo-Rodr\u00edguez, A., and Solin\u00eds, M.\u00c1. (2021). mRNA-Based Nanomedicinal Products to Address Corneal Inflammation by Interleukin-10 Supplementation. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13091472"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"120215","DOI":"10.1016\/j.ijpharm.2021.120215","article-title":"Aerosolizable siRNA-encapsulated solid lipid nanoparticles prepared by thin-film freeze-drying for potential pulmonary delivery","volume":"596","author":"Wang","year":"2021","journal-title":"Int. J. Pharm."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ejpb.2021.04.004","article-title":"Application of solid lipid nanoparticles as a long-term drug delivery platform for intramuscular and subcutaneous administration: In vitro and in vivo evaluation","volume":"163","author":"Elbrink","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"105060","DOI":"10.1016\/j.chemphyslip.2021.105060","article-title":"Intranasal solid lipid nanoparticles for management of pain: A full factorial design approach, characterization & Gamma Scintigraphy","volume":"236","author":"Khanna","year":"2021","journal-title":"Chem. Phys. Lipids"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"12243","DOI":"10.1038\/s41598-020-69276-5","article-title":"Modified solid lipid nanoparticles encapsulated with Amphotericin B and Paromomycin: An effective oral combination against experimental murine visceral leishmaniasis","volume":"10","author":"Parvez","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"886","DOI":"10.4103\/1673-5374.208546","article-title":"Dual and multi-drug delivery nanoparticles towards neuronal survival and synaptic repair","volume":"12","author":"Angelova","year":"2017","journal-title":"Neural Regen Res."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"263604","DOI":"10.1155\/2014\/263604","article-title":"Nonionic surfactant vesicles in ocular delivery: Innovative approaches and perspectives","volume":"2014","author":"Sahoo","year":"2014","journal-title":"Biomed Res. Int."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.2147\/IJN.S360740","article-title":"Dual Drug Loaded Lipid Nanocarrier Formulations for Topical Ocular Applications","volume":"17","author":"Youssef","year":"2022","journal-title":"Int. J. Nanomed."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1208\/s12249-013-0065-8","article-title":"A prospective analysis of co-processed non-ionic surfactants in enhancing permeability of a model hydrophilic drug","volume":"15","author":"Alvi","year":"2014","journal-title":"AAPS PharmSciTech."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Jacob, S., Nair, A.B., Shah, J., Gupta, S., Boddu, S.H.S., Sreeharsha, N., Joseph, A., Shinu, P., and Morsy, M.A. (2022). Lipid Nanoparticles as a Promising Drug Delivery Carrier for Topical Ocular Therapy\u2014An Overview on Recent Advances. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14030533"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1021\/acschemneuro.8b00510","article-title":"Brain delivery of curcumin using solid lipid nanoparticles and nanostructured lipid carriers: Preparation, optimization, and pharmacokinetic evaluation","volume":"10","author":"Malvajerd","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.2147\/IJN.S196681","article-title":"Energy-dependent endocytosis is responsible for drug transcorneal penetration following the instillation of ophthalmic formulations containing indomethacin nanoparticles","volume":"14","author":"Nagai","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez-Fern\u00e1ndez, F.M., Bianchera, A., Gasco, P., Nicoli, S., and Pescina, S. (2021). Lipid-Based Nanocarriers for Ophthalmic Administration: Towards Experimental Design Implementation. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13040447"},{"key":"ref_126","first-page":"150","article-title":"Effect of circulation on the disposition and ocular tissue distribution of 20 nm nanoparticles after periocular administration","volume":"14","author":"Amrite","year":"2008","journal-title":"Mol. Vis."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.colsurfb.2019.01.018","article-title":"Penetration of Nile red-loaded nanostructured lipid carriers (NLCs) across the porcine cornea","volume":"176","author":"Niamprem","year":"2019","journal-title":"Colloids Surf. B Biointerfaces."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"587997","DOI":"10.3389\/fmolb.2020.587997","article-title":"Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects","volume":"7","author":"Muraca","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"26777","DOI":"10.1039\/D0RA03491F","article-title":"A brief review on solid lipid nanoparticles: Part and parcel of contemporary drug delivery systems","volume":"10","author":"Duan","year":"2020","journal-title":"RSC Adv."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Sezer, A.D. (2012). Recent Advances in Novel Drug Carrier Systems, IntechOpen.","DOI":"10.5772\/2889"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ejpb.2018.10.017","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers: A review emphasizing on particle structure and drug release","volume":"133","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/ejlt.201200240","article-title":"Influence of lipids on the properties of solid lipid nanoparticles from microemulsion technique","volume":"115","author":"Boonme","year":"2013","journal-title":"Eur. J. Lipid Sci. Technol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.nano.2008.08.003","article-title":"Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery","volume":"5","author":"Paliwal","year":"2009","journal-title":"Nanomedicine"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s10973-019-09080-0","article-title":"Study of pre-formulation and development of solid lipid nanoparticles containing perillyl alcohol","volume":"141","author":"Cavendish","year":"2019","journal-title":"J. Therm. Anal. Calorim."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Sharma, A. (2022). Nanocomposite Materials for Biomedical and Energy Storage Applications, IntechOpen. [1st ed.].","DOI":"10.5772\/intechopen.95130"},{"key":"ref_136","first-page":"779","article-title":"Lipid nano particulate drug delivery: An overview of the emerging trend","volume":"7","author":"Balamurugan","year":"2018","journal-title":"Pharma Innov. J."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1016\/S0169-409X(02)00118-7","article-title":"Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations","volume":"54","author":"Radtke","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1049\/iet-nbt.2017.0001","article-title":"Docetaxel-loaded solid lipid nanoparticles: A novel drug delivery system","volume":"11","author":"Sumera","year":"2017","journal-title":"IET Nanobiotechnol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s10529-020-03054-1","article-title":"Surfactants: Physicochemical interactions with biological macromolecules","volume":"43","author":"Banat","year":"2021","journal-title":"Biotechnol. Lett."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"952","DOI":"10.3390\/encyclopedia2020063","article-title":"Solid Lipid Nanoparticles","volume":"2","author":"Nguyen","year":"2022","journal-title":"Encyclopedia"},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Silva, A., Martins-Gomes, C., Coutinho, T., Fangueiro, J., Sanchez-Lopez, E., Pashirova, T., Andreani, T., and Souto, E.B. (2019). Soft Cationic Nanoparticles for Drug Delivery: Production and Cytotoxicity of Solid Lipid Nanoparticles (SLNs). Appl. Sci., 9.","DOI":"10.3390\/app9204438"},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Amis, T.M., Renukuntla, J., Bolla, P.K., and Clark, B.A. (2020). Selection of Cryoprotectant in Lyophilization of Progesterone-Loaded Stearic Acid Solid Lipid Nanoparticles. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12090892"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"580118","DOI":"10.3389\/fchem.2021.580118","article-title":"Lipid Nanoparticles as Carriers for Bioactive Delivery","volume":"9","author":"Dhiman","year":"2021","journal-title":"Front. Chem."},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Siram, K., Karuppaiah, A., Gautam, M., and Sankar, V. (J. Clust. Sci., 2022). Fabrication of Hyaluronic Acid Surface Modified Solid Lipid Nanoparticles Loaded with Imatinib Mesylate for Targeting Human Breast Cancer MCF-7 Cells, J. Clust. Sci., in press.","DOI":"10.1007\/s10876-022-02265-y"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/btpr.2214","article-title":"Conjugation of melanotransferrin antibody on solid lipid nanoparticles for mediating brain cancer malignancy","volume":"32","author":"Kuo","year":"2015","journal-title":"Biotechnol. Prog."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"103527","DOI":"10.1016\/j.jddst.2022.103527","article-title":"Development and optimization of solid lipid nanoparticles coated with chitosan and poly(2-ethyl-2-oxazoline) for ocular drug delivery of ciprofloxacin","volume":"74","author":"Onugwu","year":"2022","journal-title":"J. Drug Deliv. Sci.Technol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1208\/s12249-019-1371-6","article-title":"Development, Optimization, and In Vitro\/In Vivo Characterization of Enhanced Lipid Nanoparticles for Ocular Delivery of Ofloxacin: The Influence of Pegylation and Chitosan Coating","volume":"20","author":"Eid","year":"2019","journal-title":"AAPS PharmSciTech."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/10837450.2021.1999471","article-title":"Sustained latanoprost release from PEGylated solid lipid nanoparticle-laden soft contact lens to treat glaucoma","volume":"27","author":"Dang","year":"2022","journal-title":"Pharm. Dev. Technol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2147\/DDDT.S287721","article-title":"Preparation and Characterization of Tacrolimus-Loaded SLNs in situ Gel for Ocular Drug Delivery for the Treatment of Immune Conjunctivitis","volume":"15","author":"Sun","year":"2021","journal-title":"Drug Des. Devel. Ther."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"7775","DOI":"10.2147\/IJN.S335482","article-title":"Formulation and Pathohistological Study of Mizolastine\u2013Solid Lipid Nanoparticles\u2013Loaded Ocular Hydrogels","volume":"16","author":"Girgis","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"110705","DOI":"10.1016\/j.colsurfb.2019.110705","article-title":"Dual-drugs delivery in solid lipid nanoparticles for the treatment of Candida albicans mycosis","volume":"186","author":"Carbone","year":"2020","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"7847","DOI":"10.2147\/IJN.S340068","article-title":"Assessment to the Antifungal Effects in vitro and the Ocular Pharmacokinetics of Solid-Lipid Nanoparticle in Rabbits","volume":"16","author":"Liang","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.2147\/IJN.S190502","article-title":"Natamycin solid lipid nanoparticles\u2014Sustained ocular delivery system of higher corneal penetration against deep fungal keratitis: Preparation and optimization","volume":"14","author":"Khames","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2217\/nnm-2018-0278","article-title":"Solid lipid nanoparticles for ocular delivery of isoniazid: Evaluation, proof of concept and in vivo safety & kinetics","volume":"14","author":"Singh","year":"2019","journal-title":"Nanomedicine"},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Nair, A.B., Shah, J., Al-Dhubiab, B.E., Jacob, S., Patel, S.S., Venugopala, K.N., Morsy, M.A., Gupta, S., Attimarad, M., and Sreeharsha, N. (2021). Clarithromycin Solid Lipid Nanoparticles for Topical Ocular Therapy: Optimization, Evaluation and In Vivo Studies. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13040523"},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Bonaccorso, A., Pepe, V., Zappulla, C., Cimino, C., Pricoco, A., Puglisi, G., Giuliano, F., Pignatello, R., and Carbone, C. (2021). Sorafenib Repurposing for Ophthalmic Delivery by Lipid Nanoparticles: A Preliminary Study. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13111956"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s13346-020-00733-4","article-title":"Atorvastatin-loaded solid lipid nanoparticles as eye drops: Proposed treatment option for age-related macular degeneration (AMD)","volume":"10","author":"Yadav","year":"2020","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"108906","DOI":"10.1016\/j.exer.2021.108906","article-title":"Compritol solid lipid nanoparticle formulations enhance the protective effect of betulinic acid derivatives in human M\u00fcller cells against oxidative injury","volume":"215","author":"Cheng","year":"2022","journal-title":"Exp. Eye Res."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.msec.2019.03.060","article-title":"Optimization by design of etoposide loaded solid lipid nanoparticles for ocular delivery: Characterization, pharmacokinetic and deposition study","volume":"100","author":"Ahmad","year":"2019","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"408","DOI":"10.5935\/0004-2749.20180079","article-title":"Retinal changes in rabbit after intravitreal injection of sunitinib encapsulated into solid lipid nanoparticles and polymeric nanocapsules","volume":"81","author":"Freitas","year":"2018","journal-title":"Arq. Bras. Oftalmol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"411","DOI":"10.7555\/JBR.32.20160170","article-title":"Preparation, optimization, and characterization of chitosan-coated solid lipid nanoparticles for ocular drug delivery","volume":"32","author":"Wang","year":"2018","journal-title":"J. Biomed. Res."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1167\/tvst.8.5.15","article-title":"\u03949-Tetrahydrocannabinol Derivative-Loaded Nanoformulation Lowers Intraocular Pressure in Normotensive Rabbits","volume":"8","author":"Taskar","year":"2019","journal-title":"Transl. Vis. Sci. Technol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"8115","DOI":"10.2147\/IJN.S139436","article-title":"Novel cationic lipid nanoparticles as an ophthalmic delivery system for multicomponent drugs: Development, characterization, in vitro permeation, in vivo pharmacokinetic, and molecular dynamics studies","volume":"12","author":"Wang","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"122682","DOI":"10.1016\/j.ijpharm.2023.122682","article-title":"Pre-clinical safety of topically administered sunitinib-loaded lipid and polymeric nanocarriers targeting corneal neovascularization","volume":"635","year":"2023","journal-title":"Int. J. Pharm."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/21691401.2014.909822","article-title":"Nanostructured lipid carriers and their current application in targeted drug delivery","volume":"44","author":"Jaiswal","year":"2016","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.3109\/21691401.2015.1111234","article-title":"Development of PEGylated solid lipid nanoparticles of pentoxifylline for their beneficial pharmacological potential in pathological cardiac hypertrophy","volume":"44","author":"Dhiman","year":"2016","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jsps.2021.07.015","article-title":"Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies","volume":"29","author":"Elmowafy","year":"2021","journal-title":"Saudi Pharm. J."},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Shahzadi, I., F\u00fcrst, A., Knoll, P., and Bernkop-Schn\u00fcrch, A. (2021). Nanostructured Lipid Carriers (NLCs) for Oral Peptide Drug Delivery: About the Impact of Surface Decoration. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13081312"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"150","DOI":"10.34172\/apb.2020.021","article-title":"Nanostructured Lipid Carriers: A Groundbreaking Approach for Transdermal Drug Delivery","volume":"10","author":"Chauhan","year":"2020","journal-title":"Adv. Pharm. Bull."},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Kiss, E.L., Berk\u00f3, S., G\u00e1csi, A., Kov\u00e1cs, A., Katona, G., So\u00f3s, J., Cs\u00e1nyi, E., Gr\u00f3f, I., Harazin, A., and Deli, M.A. (2019). Design and Optimization of Nanostructured Lipid Carrier Containing Dexamethasone for Ophthalmic Use. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11120679"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.ijpharm.2015.10.043","article-title":"Effect of sterilization on the physical stability of brimonidine-loaded solid lipid nanoparticles and nanostructured lipid carriers","volume":"496","author":"Farid","year":"2015","journal-title":"Int. J. Pharm."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1016\/j.xphs.2021.04.012","article-title":"The Effects of Solid and Liquid Lipids on the Physicochemical Properties of Nanostructured Lipid Carriers","volume":"110","author":"Apostolou","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jddst.2018.07.008","article-title":"Nanostructured gel for topical delivery of azelaic acid: Designing, characterization, and in-vitro evaluation","volume":"47","author":"Malik","year":"2018","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Bang, K.-H., Na, Y.-G., Huh, H.W., Hwang, S.-J., Kim, M.-S., Kim, M., Lee, H.-K., and Cho, C.-W. (2019). The Delivery Strategy of Paclitaxel Nanostructured Lipid Carrier Coated with Platelet Membrane. Cancers, 11.","DOI":"10.3390\/cancers11060807"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2147\/DDDT.S198003","article-title":"Lung cancer combination therapy: Doxorubicin and \u03b2-elemene co-loaded, pH-sensitive nanostructured lipid carriers","volume":"13","author":"Cao","year":"2019","journal-title":"Drug Des. Devel. Ther."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1515\/ntrev-2022-0109","article-title":"Nanostructured lipid carrier system: A compendium of their formulation development approaches, optimization strategies by quality by design, and recent applications in drug delivery","volume":"11","author":"Javed","year":"2022","journal-title":"Nanotechnol. Rev."},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Haider, M., Abdin, S.M., Kamal, L., and Orive, G. (2020). Nanostructured Lipid Carriers for Delivery of Chemotherapeutics: A Review. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12030288"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.biopha.2018.04.055","article-title":"Nanostructured lipid carriers for site-specific drug delivery","volume":"103","author":"Khosa","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1089\/adt.2018.898","article-title":"Repositioning of Itraconazole for the Management of Ocular Neovascularization Through Surface-Modified Nanostructured Lipid Carriers","volume":"17","author":"Selvaraj","year":"2019","journal-title":"Assay Drug Dev. Technol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.ijbiomac.2022.10.168","article-title":"Chitosan modified 5-fluorouracil nanostructured lipid carriers for treatment of diabetic retinopathy in rats: A new dimension to an anticancer drug","volume":"224","author":"Sharma","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1080\/08982104.2016.1224899","article-title":"Ocular amphotericin B delivery by chitosan-modified nanostructured lipid carriers for fungal keratitis-targeted therapy","volume":"27","author":"Fu","year":"2017","journal-title":"J. Liposome Res."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"119095","DOI":"10.1016\/j.ijpharm.2020.119095","article-title":"Chitosan oligosaccharide enhances binding of nanostructured lipid carriers to ocular mucins: Effect on ocular disposition","volume":"577","author":"Pai","year":"2020","journal-title":"Int. J. Pharm."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.ijbiomac.2020.04.115","article-title":"Trimethyl chitosan nanoparticles for ocular baicalein delivery: Preparation, optimization, in vitro evaluation, in vivo pharmacokinetic study and molecular dynamics simulation","volume":"156","author":"Li","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.actbio.2019.08.035","article-title":"Phenylboronic acid-tethered chondroitin sulfate-based mucoadhesive nanostructured lipid carriers for the treatment of dry eye syndrome","volume":"99","author":"Tan","year":"2019","journal-title":"Acta Biomater."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ijbiomac.2022.12.238","article-title":"Chondroitin sulfate and L-Cysteine conjugate modified cationic nanostructured lipid carriers: Pre-corneal retention, permeability, and related studies for dry eye treatment","volume":"228","author":"Zhu","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.2147\/IJN.S319814","article-title":"Effective Ocular Delivery of Eplerenone Using Nanoengineered Lipid Carriers in Rabbit Model","volume":"16","author":"Abdelhakeem","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41598-020-80476-x","article-title":"Thermoresponsive Genistein NLC-dexamethasone-moxifloxacin multi drug delivery system in lens capsule bag to prevent complications after cataract surgery","volume":"11","author":"Yan","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1080\/10837450.2019.1616755","article-title":"Thermosensitive hydrogel containing sertaconazole loaded nanostructured lipid carriers for potential treatment of fungal keratitis","volume":"24","author":"Tavakoli","year":"2019","journal-title":"Pharm. Dev. Technol."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ajps.2018.08.002","article-title":"A hybrid genipin-crosslinked dual-sensitive hydrogel\/nanostructured lipid carrier ocular drug delivery platform","volume":"14","author":"Yu","year":"2019","journal-title":"Asian J. Pharm. Sci."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1021\/acsbiomaterials.9b01800","article-title":"A Hybrid Genipin-Cross-Linked Hydrogel\/Nanostructured Lipid Carrier for Ocular Drug Delivery: Cellular, ex Vivo, and in Vivo Evaluation","volume":"6","author":"Yu","year":"2020","journal-title":"ACS Biomater. Sci. Eng."},{"key":"ref_192","first-page":"423","article-title":"Brinzolamide- and latanoprost-loaded nano lipid carrier prevents synergistic retinal damage in glaucoma","volume":"69","author":"Chen","year":"2022","journal-title":"Acta Biochim. Pol."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ejpb.2022.02.010","article-title":"Lactoferrin-loaded nanostructured lipid carriers (NLCs) as a new formulation for optimized ocular drug delivery","volume":"172","author":"Regueiro","year":"2022","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_194","doi-asserted-by":"crossref","unstructured":"Kumari, S., Dandamudi, M., Rani, S., Behaeghel, E., Behl, G., Kent, D., O\u2019Reilly, N.J., O\u2019Donovan, O., McLoughlin, P., and Fitzhenry, L. (2021). Dexamethasone-Loaded Nanostructured Lipid Carriers for the Treatment of Dry Eye Disease. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13060905"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"4702","DOI":"10.1002\/jcp.27243","article-title":"Nanostructured lipid carriers containing rapamycin for prevention of corneal fibroblasts proliferation and haze propagation after burn injuries: In vitro and in vivo","volume":"234","author":"Khonsari","year":"2019","journal-title":"J. Cell Physiol."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.sjbs.2021.11.006","article-title":"Itraconazole loaded nano-structured lipid carrier for topical ocular delivery: Optimization and evaluation","volume":"29","author":"Kumar","year":"2022","journal-title":"Saudi J. Biol. Sci."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/j.xphs.2018.04.014","article-title":"Formulation Development, Optimization, and In Vitro-In Vivo Characterization of Natamycin-Loaded PEGylated Nano-Lipid Carriers for Ocular Applications","volume":"107","author":"Patil","year":"2018","journal-title":"J. Pharm. Sci."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1039\/D0BM01599G","article-title":"Dasatinib loaded nanostructured lipid carriers for effective treatment of corneal neovascularization","volume":"9","author":"Li","year":"2021","journal-title":"Biomater. Sci."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1080\/10717544.2022.2048134","article-title":"Sorafenib-loaded nanostructured lipid carriers for topical ocular therapy of corneal neovascularization: Development, in-vitro and in vivo study","volume":"29","author":"Luo","year":"2022","journal-title":"Drug Deliv."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"110902","DOI":"10.1016\/j.colsurfb.2020.110902","article-title":"Triamcinolone acetonide loaded-cationic nano-lipoidal formulation for uveitis: Evidences of improved biopharmaceutical performance and anti-inflammatory activity","volume":"190","author":"Nirbhavane","year":"2020","journal-title":"Colloids Surf. B. Biointerfaces"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"105991","DOI":"10.1016\/j.ejps.2021.105991","article-title":"Topical ocular delivery of vancomycin loaded cationic lipid nanocarriers as a promising and non-invasive alternative approach to intravitreal injection for enhanced bacterial endophthalmitis management","volume":"167","author":"Jounaki","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3389\/fphar.2018.00285","article-title":"Innovative Nanoparticles Enhance N-Palmitoylethanolamide Intraocular Delivery","volume":"9","author":"Puglia","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_203","doi-asserted-by":"crossref","unstructured":"Zingale, E., Rizzo, S., Bonaccorso, A., Consoli, V., Vanella, L., Musumeci, T., Spadaro, A., and Pignatello, R. (2022). Optimization of Lipid Nanoparticles by Response Surface Methodology to Improve the Ocular Delivery of Diosmin: Characterization and In-Vitro Anti-Inflammatory Assessment. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14091961"},{"key":"ref_204","doi-asserted-by":"crossref","unstructured":"Santonocito, D., Vivero-Lopez, M., Lauro, M.R., Torrisi, C., Castelli, F., Sarpietro, M.G., and Puglia, C. (2022). Design of Nanotechnological Carriers for Ocular Delivery of Mangiferin: Preformulation Study. Molecules, 27.","DOI":"10.3390\/molecules27041328"},{"key":"ref_205","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez-Fern\u00e1ndez, F.M., Delledonne, A., Nicoli, S., Gasco, P., Padula, C., Santi, P., Sissa, C., and Pescina, S. (2023). Nanostructured Lipid Carriers for Enhanced Transscleral Delivery of Dexamethasone Acetate: Development, Ex Vivo Characterization and Multiphoton Microscopy Studies. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15020407"},{"key":"ref_206","doi-asserted-by":"crossref","unstructured":"Khairnar, S.V., Pagare, P., Thakre, A., Nambiar, A.R., Junnuthula, V., Abraham, M.C., Kolimi, P., Nyavanandi, D., and Dyawanapelly, S. (2022). Review on the Scale-Up Methods for the Preparation of Solid Lipid Nanoparticles. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14091886"},{"key":"ref_207","doi-asserted-by":"crossref","unstructured":"Duong, V.-A., Nguyen, T.-T.-L., and Maeng, H.-J. (2020). Preparation of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Drug Delivery and the Effects of Preparation Parameters of Solvent Injection Method. Molecules, 25.","DOI":"10.3390\/molecules25204781"},{"key":"ref_208","doi-asserted-by":"crossref","unstructured":"Zieli\u0144ska, A., Soles, B.B., Lopes, A.R., Vaz, B.F., Rodrigues, C.M., Alves, T.F.R., Klensporf-Pawlik, D., Durazzo, A., Lucarini, M., and Severino, P. (2020). Nanopharmaceuticals for Eye Administration: Sterilization, Depyrogenation and Clinical Applications. Biology, 9.","DOI":"10.3390\/biology9100336"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ijpharm.2011.07.040","article-title":"Development of an itraconazole-loaded nanostructured lipid carrier (NLC) formulation for pulmonary application","volume":"419","author":"Pardeike","year":"2011","journal-title":"Int. J. Pharm."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijpharm.2008.07.028","article-title":"Cyclosporine A loaded SLNs: Evaluation of cellular uptake and corneal cytotoxicity","volume":"364","author":"Gokce","year":"2008","journal-title":"Int. J. Pharm."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"105887","DOI":"10.1016\/j.ejps.2021.105887","article-title":"Gamma sterilization and in vivo evaluation of cationic nanostructured lipid carriers as potential ocular delivery systems for antiglaucoma drugs","volume":"163","author":"Youshia","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_212","doi-asserted-by":"crossref","unstructured":"Thi, T.T.H., Suys, E.J.A., Lee, J.S., Nguyen, D.H., Park, K.D., and Truong, N.P. (2021). Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines. Vaccines, 9.","DOI":"10.3390\/vaccines9040359"},{"key":"ref_213","doi-asserted-by":"crossref","unstructured":"Khiev, D., Mohamed, Z.A., Vichare, R., Paulson, R., Bhatia, S., Mohapatra, S., Lobo, G.P., Valapala, M., Kerur, N., and Passaglia, C.L. (2021). Emerging Nano-Formulations and Nanomedicines Applications for Ocular Drug Delivery. Nanomaterials, 11.","DOI":"10.3390\/nano11010173"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejps.2017.10.042","article-title":"The application of Quality by Design framework in the pharmaceutical development of dry powder inhalers","volume":"113","author":"Buttini","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.addr.2017.04.001","article-title":"Nanoparticles for drug delivery to the anterior segment of the eye","volume":"122","author":"Janagam","year":"2017","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/16\/3\/474\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:00:57Z","timestamp":1760122857000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/16\/3\/474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,22]]},"references-count":215,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["ph16030474"],"URL":"https:\/\/doi.org\/10.3390\/ph16030474","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,22]]}}}